ijms-logo

Journal Browser

Journal Browser

Canonical and Noncanonical Inflammasomes in Inflammation and Diseases

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".

Deadline for manuscript submissions: 30 November 2025 | Viewed by 345

Special Issue Editor

Special Issue Information

Dear Colleagues,

The inflammasome is an intracellular protein complex that provides a molecular platform for inflammatory responses to a variety of the pathogen-associated molecular patterns (PAMPs) or danger-associated molecular patterns (DAMPs). The inflammasome is classified into canonical and noncanonical inflammasomes, and has been demonstrated to play a crucial role in inflammation and diseases. However, the roles of both canonical and noncanonical inflammasomes, as well as how their dysregulation contributes to inflammatory responses and diseases, are still not well understood and require further investigation.

This Special Issue aims to investigate the regulatory roles of both canonical and noncanonical inflammasomes in inflammation and diseases and to provide insights into the development of new anti-inflammatory therapeutics by targeting inflammasomes.

Potential topics include but are not limited to

  1. the roles of canonical and noncanonical inflammasomes in inflammatory responses and human diseases,
  2. the underlying mechanisms,
  3. identifying and validating novel molecules interplaying with inflammasomes,
  4. evaluating anti-inflammatory effects by targeting inflammasomes, and
  5. developing potential inflammasome-targeted therapeutics.

Dr. Young-Su Yi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • canonical
  • noncanonical
  • inflammasome
  • inflammation
  • human diseases
  • anti-inflammatory therapeutics

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Related Special Issue

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

18 pages, 1832 KB  
Review
Regulatory Roles of Noncanonical Inflammasomes in Diabetes Mellitus and Diabetes-Associated Complications
by Young-Su Yi
Int. J. Mol. Sci. 2025, 26(18), 8893; https://doi.org/10.3390/ijms26188893 - 12 Sep 2025
Viewed by 202
Abstract
Inflammation is an innate immune system protecting the body from infection and injury. This process proceeds through two distinct stages: a priming phase, characterized by transcriptional activation, and a triggering phase, in which inflammasomes, cytosolic multiprotein complexes, are activated to initiate inflammatory signaling [...] Read more.
Inflammation is an innate immune system protecting the body from infection and injury. This process proceeds through two distinct stages: a priming phase, characterized by transcriptional activation, and a triggering phase, in which inflammasomes, cytosolic multiprotein complexes, are activated to initiate inflammatory signaling cascades. Canonical inflammasomes, the first to be identified, have been extensively implicated in the pathogenesis of diverse inflammatory disorders. In contrast, noncanonical inflammasomes have only recently been characterized, and their precise contributions to immune regulation and disease development remain incompletely defined. Diabetes mellitus (DM), simply diabetes, represents a heterogeneous group of metabolic disorders marked by chronic hyperglycemia and is associated with a broad spectrum of complications. The involvement of canonical inflammasomes in DM and its complications has been well demonstrated. More recently, however, accumulating evidence has uncovered crucial roles for noncanonical inflammasomes in the pathogenesis of DM and related complications This review comprehensively discusses current advances in understanding the regulatory functions of murine caspase-11 and human caspase-4/5 noncanonical inflammasomes in the pathogenesis of DM and diabetes-associated complications, highlighting their potential as novel therapeutic targets. Full article
(This article belongs to the Special Issue Canonical and Noncanonical Inflammasomes in Inflammation and Diseases)
Show Figures

Figure 1

Back to TopTop